U.S. markets closed
  • S&P 500

    4,063.04
    -89.06 (-2.14%)
     
  • Dow 30

    33,587.66
    -681.50 (-1.99%)
     
  • Nasdaq

    13,031.68
    -357.75 (-2.67%)
     
  • Russell 2000

    2,135.14
    -71.85 (-3.26%)
     
  • Crude Oil

    65.79
    -0.29 (-0.44%)
     
  • Gold

    1,815.50
    -7.30 (-0.40%)
     
  • Silver

    27.11
    -0.13 (-0.47%)
     
  • EUR/USD

    1.2079
    -0.0073 (-0.60%)
     
  • 10-Yr Bond

    1.6950
    +0.0710 (+4.37%)
     
  • GBP/USD

    1.4060
    -0.0084 (-0.60%)
     
  • USD/JPY

    109.6830
    +1.0630 (+0.98%)
     
  • BTC-USD

    53,484.07
    -3,037.23 (-5.37%)
     
  • CMC Crypto 200

    1,475.23
    -88.60 (-5.67%)
     
  • FTSE 100

    7,004.63
    +56.64 (+0.82%)
     
  • Nikkei 225

    28,147.51
    -461.08 (-1.61%)
     

Cronos: 4Q Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.

TORONTO (AP) _ Cronos Group Inc. (CRON) on Friday reported a fourth-quarter loss of $111.2 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Toronto-based company said it had a loss of 31 cents. Losses, adjusted for non-recurring costs and to account for discontinued operations, were 19 cents per share.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 6 cents per share.

The cannabis company posted revenue of $17 million in the period, which topped Street forecasts. Five analysts surveyed by Zacks expected $13.8 million.

For the year, the company reported a loss of $75.3 million, or 21 cents per share, swinging to a loss in the period. Revenue was reported as $46.7 million.

Cronos shares have climbed 55% since the beginning of the year. The stock has climbed 79% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRON at https://www.zacks.com/ap/CRON